Oncolytics gears up for Phase III trial in HR+/HER2- breast cancer
Plans for the registrational trial were teased in the announcement of positive results from a Phase II trial investigating pelareorep.
Pharma industry mixed on outlook of decentralised trials
Pharma world braces for major changes in new era of AI
Michael J. Fox Foundation teams up with H1 to drive PD research engagement
Allgenesis touts preliminary data from Phase IIa diabetic macular oedema trial
China-based HanX earns FDA greenlight for US lymphoma trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreShionogi starts Phase I trial of Covid-19 antiviral in Japan
The trial will assess the pharmacokinetics, safety, and tolerability of S-892216 in healthy adults.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
It’s a match! Connecting patients to clinical trials with AI
Netramark unveils ChatGPT-based clinical trial de-risking technology
Navigating uncertainty: How Covid-19 has changed the CRO and sponsor dynamic
Novavax employs AI-based dose selection for Covid-influenza vaccine trials